Lupin appoints Nicholas Hart head for US business

Mumbai based Pharmacy company has announced the appointment of Nicholas Hart as the head of company's specialty business. Mr Hart joins as President of this division and will lead Lupin’s Specialty brand business growth strategy and profit and loss.

With over 25 years of specialty business, strategic and commercial operations experience Hart according to Lupin has led the launch of numerous products both globally and in the US in multiple therapeutic areas, including Women’s Health. His past experiences include Business Unit Head for Reproductive Health at Ferring Pharmaceuticals, Inc and Senior Vice President of Sales and Marketing at URL Pharma.

“We are delighted to welcome Nick to Lupin at a crucial time as we prepare to launch Solosec in the US market and accelerate efforts to build our Specialty business. His knowledge and experience in the industry will be valuable for our growth aspirations in the US market.” said Vinita Gupta, Chief Executive Officer, Lupin.